Immunolymphoscintigraphy in breast cancer: Evaluation using 131I- labeled monoclonal antibody B72.3

Nuclear Medicine and Biology

Volumn 25, Issue 3, 1998, Pages 251-260

  Fig, Lorraine M ^a   Brown, Raya S ^a   Von Moll, Lisa ^a   Appelman, Henry D ^b   Stevens, Ralph ^b   Harness, Jay ^b   August, David ^b   Sondak, Vernon K ^b   Chang, Alfred E ^b   Zasadny, Kenneth R ^a   Fisher, Susan J ^a   Johnson, Jon W ^a   Wicha, Max S ^a   Colcher, David ^c   Lichter, Allen S ^b   Wahl, Richard L ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^c UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Breast neoplasm; Iodine radioisotopes; Lymphatic metastasis; Monoclonal antibodies; Radionuclide imaging

Indexed keywords

MONOCLONAL ANTIBODY B.72.3 I 131;

ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER DIAGNOSIS; CANCER STAGING; CLINICAL ARTICLE; DRUG UPTAKE; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOSCINTIGRAPHY; INTRATUMORAL DRUG ADMINISTRATION; LYMPH NODE METASTASIS; LYMPHOSCINTIGRAPHY; SUBCUTANEOUS DRUG ADMINISTRATION;

ANTIBODIES, MONOCLONAL; ANTIBODIES, NEOPLASM; ANTIGENS, NEOPLASM; BREAST NEOPLASMS; FEMALE; GLYCOPROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; IODINE RADIOISOTOPES; LYMPH NODES; LYMPHATIC METASTASIS; NEOPLASM STAGING; RADIOIMMUNODETECTION; RADIOPHARMACEUTICALS;

EID: 0032054149     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8051(97)00172-8     Document Type: Article

References (52)

1. 1. American Joint Committee on Cancer (1988) Manual for Staging of Cancer, 3rd edn. J. B. Lippincott, Philadelphia.
2. 2. Boova R. S., Bonanni R. and Rosato F. E. (1982) Patterns of axillary nodal involvement in breast cancer: Predictability of level one dissection. Ann. Surg. 196, 642-644.
3. 3. Colcher D., Horan Hand P., Nuti M. and Schlom J. (1981) A spectrum of monoclonal antibodies reactive with human mammary tumor cells. Proc. Nad. Acad. Sci. USA 78, 3119-3203.
4. 4. DeLand F. H., Kim E. E., Corgan R. L., et al. (1979) Axillary lymphoscintigraphy by radioimmunodetection of carcinoembryonic antigen in breast cancer. J. Nucl. Med. 20, 1243-1250.
5. 5. DeLand F. H., Kim E. E. and Goldenberg D. M. (1980) Lymphoscintigraphy with radionuclide labeled antibodies to carcinoembryonic antigen. Cancer Res. 40, 2997-3000.
6. 6. DeLand F. H. and Goldenberg D. M. (1985) Diagnosis and treatment of neoplasms with radionuclide-labeled antibodies. Semin. Nucl. Med. 15, 2-11.
7. 7. Ege G. N. (1983) Lymphoscintigraphy: Technique and applications in the management of breast carcinoma. Semin. Nucl. Med. 13, 26-34.
8. 8. Engelstad B. L., Spitler L. E., Del Rio M. J., et al. (1986) Phase I immunolymphoscintigraphy with an In-111 labeled antimelanoma monoclonal antibody. Radiology 161, 419-422.
9. 9. Epenetos A. A. (1985) Antibody guided lymphangiography in the staging of cervical cancer. Br. J. Cancer 51, 805-808.
10. 10. Fidler I. J., Gersten D. M. and Hart I. R. (1978) The biology of cancer invasion and metastasis. Adv. Cancer Res. 28, 149-250.
11. 11. Fraker P. J. and Speck J. C. Jr. (1978) Protein and cell membrane iodinations with a sparingly soluble chloramide, 1,3,4,6-tetrachloro-3a,6a-diphenylglycoluril. Biochem. Biophys. Res. Commun. 80, 849-857.
12. 12. Giuliano A. E., Dale P. S., Turner R. R., Morton D. L., Evans S. W. and Krasne D. L. (1995) Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann. Surg. 222, 394-399.
13. 13. Goldenberg D. M. and Larson S. M. (1992) Radioimmunodetection in cancer identification. J. Nucl. Med. 33, 803-814.
14. 14. Greiner J. W., Horan Hand P., Colcher D., et al. (1987) Modulation of human tumor antigen expression. J. Lab. Clin. Med. 109, 244-261.
15. 15. Harris J. R., Hellman S., Canellos G. P. and Fisher B. (1985) Cancer of the breast. In: Cancer: Principles and Practice of Oncology, 2nd edn. (Edited by De Vita V. T., Hellman S. and Rosenberg S. A.), pp. 1119-1177. J. B. Lippincott, Philadelphia.
16. 16. Hendler F. J. and House D. (1985) Presence of breast cancer antigens in uninvolved axillary lymph nodes. Cancer Res. 45, 3364-3373.
17. 17. Horan Hand P., Nuti M., Colcher D. and Schlom J. (1983) Definition of antigenic heterogeneity and modulation among human mammary carcinoma cell populations using monoclonal antibodies to tumor-associated antigens. Cancer Res. 43, 728-735.
18. 18. Hsue S. M., Raine L. and Fanger H. (1981) Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabelled antibody (PAP) procedures. J. Histochem. Cytochem. 29, 577-580.
19. 19. Johnson V. G., Schlom J., Paterson A. J., Bennett J., Magnani J. L. and Colcher D. (1986) Analysis of a human tumor-associated glycoprotein (TAG-72) identified by monoclonal antibody B72.3. Cancer Res. 46, 850-857.
20. 20. Johnston W. W., Szpak C. A., Lottich S. C., Thor A. and Schlom J. (1986) Use of a monoclonal antibody (B72.3) as a novel immunohistochemical adjunct for the diagnosis of carcinomas in fine needle aspiration biopsy specimens. Hum. Pathol. 17, 501-513.
21. 21. Kairemo K. J. A. (1990) Immunolymphoscintigraphy with 99mTc-labeled monoclonal antibody (BW 431/26) reacting with carcinoembryonic antigen in breast cancer. Cancer Res. 50, 949S-954S.
22. 22. Keenan A. M. (1989) Immunolymphoscintigraphy. Semin. Nucl. Med. 19, 322-331.
23. 23. Kinne D. W. (1991) The surgical management of primary breast cancer. CA Cancer J. Clin. 41, 71-84.
24. 24. Kopans D. B. (1989) Breast Imaging. J. B. Lippincott, Philadelphia.
25. 25. Lamki L. M., Buzdar A. U., Singletary S. E., et al. (1991) Indium-111-labeled B72.3 monoclonal antibody in the detection and staging of breast cancer: A phase I study. J. Nucl. Med. 32, 1326-1332.
26. 26. Larson S. M. (1985) Radiolabeled monoclonal anti-tumor antibodies in diagnosis and therapy. J. Nucl. Med. 26, 538-545.
27. 2 fragments of monoclonal antibody OC125. Cancer Res. 50, 937S-940S.
28. 28. Mandeville R., Pateisky N., Philipp K., Kubista E., Dumas F. and Grouix B. (1986) Immunolymphoscintigraphy of axillary lymph node metastases in breast cancer using monoclonal antibodies: First clinical findings. Anticancer Res. 6, 1257-1264.
29. 29. McLean R. G. and Ege G. N. (1986) Prognostic value of axillary lymphoscintigraphy in breast carcinoma patients. J. Nucl. Med. 27, 1116-1124.
30. 30. Nelp W. B., Eary J. F. and Jones R. F. (1987) Preliminary studies of monoclonal antibody lymphoscintigraphy in malignant melanoma. J. Nucl. Med. 28, 34-41.
31. 31. Nieroda C. A., Mojzisik C., Sardi A., et al. (1989) Staging of carcinoma of the breast using a hand-held gamma detecting probe and monoclonal antibody B72.3. Surg. Gynecol. Obstet. 169, 35-40.
32. 32. Nuti M., Teramoto Y. A., Mariani-Constantini R., Horan Hand P., Colcher D. and Schlom J. (1982) A monoclonal antibody (B72.3) defines patterns of distribution of a novel tumor-associated antigen in human mammary carcinoma cell populations. Int. J. Cancer 29, 539-545.
33. 33. Order S. E., Bloomer W. D., Jones A. G., et al. (1975) Radionuclide immunoglobulin lymphangiography: A case report. Cancer 35, 1487-1492.
34. 34. Pressman D., Day E. D. and Blau M. (1957) The use of paired labeling in the determination of tumor-localizing antibodies. Cancer Res. 17, 845-850.
35. 35. Schlom J., Greiner J., Horan Hand P., et al. (1984) Monoclonal antibodies to breast cancer-associated antigens as potential reagents in the management of breast cancer. Cancer 54, 2777-2794.
36. 36. Shah S. A., Gallagher B. M. and Sands H. (1987) Lymphoscintigraphy of human colorectal carcinoma metastases in athymic mice by use of radioiodinated B72.3 monoclonal antibody. J. Natl. Cancer Inst. 78, 1069-1077.
37. 37. Sheer D. G., Schlom J. and Cooper H. L. (1988) Purification and composition of human tumor-associated glycoprotein (TAG-72) defined by monoclonal antibodies CC49 and B72.3. Cancer Res. 48, 6811-6818.
38. 38. Shibata H. R. (1983) Editorial: Lymphoscintigraphy in the staging of breast cancer. Can. J. Surg. 26, 487-488.
39. 39. Soomro S. and Shousha S. (1992) Monoclonal antibody B72.3 immunostaining of breast carcinoma: Patterns of staining and relationship to mucin content and GCDFP-15 reactivity. Arch. Pathol. Lab. Med. 16, 32-35.
40. 40. Stein G. H. and Yanishevsky R. (1979) Autoradiography. In: Methods in Enzymology: Cell Culture (Edited by Jacoby W. B. and Pastan I. A.), pp 279-292. Academic Press, New York.
41. 41. Tavassoli F. A., Jones M. V., Majeste R. M., Bratthauer G. L. and O'Leary T. J. (1990) Immunohistochemical staining with monoclonal antibody B72.3 in benign and malignant breast disease. Am. J. Surg. Pathol. 14, 128-133.
42. 42. Thompson C. H., Lichtenstein M., Stacker S. A., et al. (1984) Immunoscintigraphy for detection of lymph node metastases from breast cancer. Lancet 2, 1245-1247.
43. 43. Thor A., Ohuchi N., Szpak C. A., Johnston W. W. and Schlom J. (1986) Distribution of oncofetal antigen tumor-associated glycoprotein-72 defined by monoclonal antibody B72.3. Cancer Res. 46, 3118-3124.
44. 44. Thor A. D. and Edgerton S. M. (1989) Monoclonal antibodies reactive with human breast or ovarian carcinoma: In vivo applications. Semin. Nucl. Med. 19, 295-308.
45. 45. Tjandra J. J., Russell I. S., Collins J. P., et al. (1989) Immunolymphoscintigraphy for the detection of lymph node metastases from breast cancer. Cancer Res. 49, 1600-1608.
46. 46. Tjandra J. J., Sacks N. P. M., Thompson C. H., et al. (1989) The detection of axillary lymph node metastases from breast cancer by radiolabeled monoclonal antibody: A prospective study. Br. J. Cancer 59, 296-302.
47. 47. Wahl R. L, Liebert M., Headington J., et al. (1990) Lymphoscintigraphy in melanoma: Initial evaluation of a low protein dose monoclonal antibody cocktail. Cancer Res. 50, 941S-948S.
48. 48. Weinstein J. N., Steller M. A., Keenan A. M., et al. (1983) Monoclonal antibodies in the lymphatics: Selective delivery to lymph node metastases of a solid tumor. Science 222, 423-426.
49. 49. Weinstein J. N. (1990) Antibody lymphoscintigraphy. Cancer Treat. Res. 51, 365-385.
50. 50. Wiener J. I., Chako A. C., Merten C. W., Gross S., Coffey E. L. and Stein H. L. (1986) Breast and axillary tissue MR imaging: Correlation of signal intensities and relaxation times with pathologic findings. Radiology 160, 299-305.
51. 51. Wilson R. E., Donegan W. L, Mettlin C., Natarajan N., Smart C. R. and Murphy G. P. (1984) The 1982 national survey of carcinoma of the breast in the United States by the American College of Surgeons. Surg. Gynecol. Obstet. 159, 309-318.
52. 52. Yang F. E., Brown R. S., Koral K. F., Clavo A. C., Jackson G. A. and Wahl R. L. (1992) Quantitative autoradiographic evaluation of the influence of protein dose on monoclonal antibody distribution in human ovarian adenocarcinoma xenografts. Cancer Immunol. Immunother. 35, 365-372.